Ozempic made Novo Nordisk a pharmaceutical superstar, but the real news is Wegovy : in August 2025, the FDA granted him an accelerated approval to treat the MASHfurther expanding the NVO playground. Good news for crypto-investors: the action Novo Nordisk also exists in Tokenized version (nvox)buyable directly from a walleton Dex, 24/7 et sans KYC. So buy NVO on the blockchain will it get fat … or lose your portfolio?
This article is offered to you by 21m ⭕, the Cryptos investor community causing the Club 25%.
This article contains affiliation links allowing you to support the daily work of the teams in the local newspaper.
What is Novo Nordisk? Should we buy now?
Novo Nordisk A/s (NVVO) is a Danish pharmaceutical company founded in 1923, specializing in the treatment of diabetes, obesity and metabolic diseases. Listed at the Nasdaq in Copenhagen and via Adr in the NYSE, it is today the first European market capitalization, carried by the success of its innovative treatments. In 2024, Novo Nordisk produced $ 39.6 billion in turnoverup 31 % compared to 2023, with record operating margin of more than 44 %. Novo Nordisk derives its income from several strategic segments:
Diabetes : GLP-1 insulins and agonists like Ozempic, which has become a world blockbuster;
Obesity : Wegovy, specifically indicated for weight loss, now one of the most requested treatments in the world;
Rare diseases : hemophilia and endocrine disorders;
Cardiovascular and metabolic : Recent expansion to new indications (Mash, heart disease). In August 2025, the FDA granted Wegovy a Accelerated approval for the treatment of Mash (metabolic steato-hepatitis)a liver disease that affects approximately 5 % of American adults. This decision considerably expands the potential Novo Nordisk market beyond obesity and constitutes a major catalyst for the future growth of the company and its share on the stock market.
Read also: How to buy the tokenized action of Circle (CRCL)?
Why buy Novo Nordisk (NVO) via Tokens rather than via a classic broker?
Buying the NOVO Nordisk action in token form allows you to bypass a good number of constraints specific to traditional financial markets: no need to go through a conventional broker, to open a bank account or to fill a complete KYC. Another major difference: the standard T+2 settlement period disappears, replaced by an almost instantaneous execution. The acquisition is made directly from a crypto walletwith continuous accessibility 24/7. To better understand, here is a simple comparison of the advantages and limits of the purchase of Novo Nordisk (NVO) shares in token version, facing traditional stock markets:
✅ Advantages❌ DisadvantagesContinuous open markets (DEX) : possibility of trader 24 hours a day, 7 days a weekwithout binding hoursStill limited liquidity : Watch out for Spreads and Slippage during big ordersSimplified management : you keep your NVOx directly in your crypto walletYoung intermediaries : Blockchain platforms remain less proven than traditional brokersGlobal accessibility : no geographic brake on investmentNo shareholder rights : neither dividends in cash nor voting rightDEFI integration : possibility of using NVOx as collateral or place it in protocols (pools, lending, etc.)Almost instantaneous transfers : regulation in a few secondsPossible tax optimization : No immediate taxation as long as you stay in on-chain (excluding Fiat conversion)No kyc : direct purchase without compulsory identity verificationNo necessary bank : everything is done in crypto, independently in view of these advantages, the comparison between a classic action and its token version quickly turns to the advantage of the blockchain model. For the investor, direct access, simplicity of use and permanent availability make it a difficult to ignore.
Invest in Novo Nordisk (Nvox) on the blockchain: the 2 access roads
You have two access routes To invest in tokenized action Novo Nordisk :
Primary market (Mint) : you create new nvox with the transmitter via a MINTING process. You become the first holder of these tokens, it is generally preferred by qualified investors who make a KYC ;
Secondary market (DEX) : you buy Nvox already issued by other investors, directly on a decentralized exchange. These tokens have a History on-chain – the equivalent of an “second -hand market” of the token – with the advantage of a immediate execution et sans KYC.
CriteriaBacked FinanceSecondary market (DEX)ActiveToken 1: 1 leaning against real actions 1: 1 backed by actual actionsBlockchainEtherum, Solan, arbitrator, Basketum, Solana, arbitrum, baseAction to actionYes (1 token = 1 real action) Yes (1 token = 1 real action)RegulationCorporated company with unregulated jerseyenization (DEFI)KYC RequiemCompulsory on the primary market; not compulsory on the secondary market.NonShareholder rightsNeither right to dividends, nor right to vote right to dividends, nor the right to vote in summary: for a particular investor, the primary market does not provide any particular benefit. Purchase of action Novo Nordisk (NVOx) on the secondary market There remains the simplest solution: you can invest in a few minutes, directly from your crypto wallet, and above all Without having to go through a kyc procedure.
Buy Novo Nordisk (Nvox) on the blockchain step by step
Here's how to easily invest in action Novo Nordisk tokenisée (NVOx) Using the Solana blockchain and decentralized exchanges (DEX):
1️⃣ Install your Solana Wallet
The first step is to create a Solana Crypto compatible portfolio. We recommend Phantomeasy to use, secure and directly integrated into your browser. Go to Phantom.App; Install the extension on Chrome, Firefox or Brave; Create a wallet and carefully keep your secret sentence.
2️⃣ Place USDC on your Wallet Solana
You will need USDC (SPL) To buy nvox. Two possibilities:
Since a centralized exchange (CEX) : Buy USDC on Binance, Coinbase or other, then remove them in Solara network to your Phantom address;
From another blockchain : if your USDC are on Ethereum or Arbitrum, use a bridge like Wormhole To transfer them to Solana. ⚠️ Always check that you use The Solana network and the right address before validating a transfer.
3️⃣ exchange your USDC for nvox via Jupiter
Once your USDC is in Phantom: Go to Jupiter; Select USDC In «From» and NVOx in «To»; Indicate the amount to exchange and confirm the transaction in Phantom; Jupiter aggregates the available liquidity (Raydium, etc.) to obtain the best price.
4️⃣ store your nvox and explore the deffi
Congratulations ! You now hold Novo Nordisk shares in token version. And if you now want to discover how to have yield on your tslax (kinds of DEFI dividends), and access the best DEFI opportunities to generate passive yield, you can join us in the club 25% :
The opinion of 21m ⭕ on the purchase of XNOV
21m ⭕ is the Cryptos investor community behind the Club 25%a strategy designed to generate a stable yield of 25% per year, for 10 years, without active trading.
Tokenized actions represent in our eyes a new stage in the investment. They offer the possibility of buying or selling in a few seconds, directly from a crypto wallet, with continuous accessible liquidity, 24/7. No more constraints of banks or conventional brokers, and, depending on the platforms, more compulsory KYC. An additional advantage: you can manage your positions without generating immediate tax eventsas long as you stay in the on-chain ecosystem.
Is Novo Nordisk a good choice of investment? The Danish company has a major asset: Ozempicbecome one of the most popular drugs in the world, which has redefined the management of diabetes and obesity. This emblematic product continues to generate colossal income and Novo Nordisk place in the position of undisputed leader in the wave of GLP-1 treatments. The real novelty, and undoubtedly the most underestimated catalyst today is theWegovy indication extension (semaglutide) for the mash Validated by the FDA in August 2025. This green light opens a new market estimated at several million patients, with a considerable recurring income potential and a valuation which could be directly reinforced. For a crypto investor, the version NVOX tokenized allows to expose themselves to this potential directly from a Wallet, without intermediary, and to benefit from a Almost instant liquidity. This is typically the kind of opportunity that we closely monitor: a flagship product (Ozempic), an exceptional stock market momentum, and simplified accessibility thanks to the blockchain. In any case, the action Novo Nordisk is not part of our direct investment perimeter with the portfolio the 100,000 $. On the other hand, it is quite possible to obtain Additional returns On tokenized actions like nvox by using them in the DEFI ecosystem. Click on the image just below to access it:
FAQ – 7 questions about Novo Nordisk (NVO) in token version
1. What is a NOVO Nordisk tokenized action?
A novo northern tokenized action, as NVOxis a digital asset that replies 1: 1 The price of the Novo Nordisk (ADR) action listed on the stock market. It is issued by a regulated supplier (Backed Assets) and can be exchanged directly on the blockchain, via Dex like Jupiter on Solana.
2. What difference between Nvox and a classic action?
The classic action is owned via a traditional broker, with voting rights and dividends. Nvox, on the other hand, does not confer No shareholder rights : It is an economic exposure to the price of the action, but without dividend or the right to vote.
3. Can we buy Novo Nordisk tokenized without kyc?
Yes. By going through the secondary market (DEX), you can acquire NVOx Directly from a crypto wallet, without identity verification, 24/7.
4. What are the advantages in relation to the purchase of a classic action?
Global accessibility, almost instant settlement, possibility of splitting the investment from $ 1, continuous trading (24/7), and no time.
5. Can we perceive dividends with Nvox?
No. The tokenized version of Novo Nordisk does not grant Neither dividends in cash nor voting rights. It is only an exhibition at the price of action.
6. Why invest in Novo Nordisk now?
Thanks to the colossal success of its treatments GLP-1 (Ozempic for diabetes, Wegovy for obesity), Novo Nordisk has become the world leader in this segment. In August 2025, the FDA approved Wegovy to treat the masha liver disease affecting millions of patients: a major catalyst for the future growth of the title.
7. How many tokenized actions do you have in the $ 100,000 portfolio?
To have the answer, click on this link that will take you directly to 21m ⭕.